Jump to content
IndiaDivine.org

Mediterranean populations- Stidies indicate disease significantly lower

Rate this topic


Guest guest

Recommended Posts

Guest guest

Olive Oil

http://nutra-smart.net/olive.htm

 

Statistics have shown that Mediterranean populations such as Spain,

Italy & Greece, have significantly lower rates of coronary heart

disease (CHD) than that seen throughout the rest of the world. [1] This

observation was initially met with confusion, because the typical Mediterranean

diet is moderately high in fat.

 

Because studies among these other populations had shown a

significant association between fat intake and the risk of heart disease, it was

not known why the reverse was true among the Mediterranean people.

 

It was soon discovered that it was the " quality " , not the quantity of fat which

was associated with heart disease. The fat intake of typical American diets

consisted largely of saturated fats from animal foods such as meat and dairy,

whereas the fat intake among typical Mediterranean diets consisted largely of

monounsaturated fats from plant sources such as olive oil. It was then

discovered that diets high in monounsaturated fatty acids (MUFA's) and low in

saturated fatty acids

(SUFA's) could favourably affect blood cholesterol levels and

consequently decrease the risk of developing cardiovascular diseases

such as coronary heart disease (CHD); even when providing the same

amount of total fat.

 

Further studies have revealed that other than its high MUFA content,

unprocessed (extra-virgin) olive oil contains non-fat components

such as certain " phenolic " compounds which have been found to have a wide range

of beneficial health effects which include favourable effects on cholesterol

(both 'good' and 'bad') levels and oxidation, as well as

posessing an anti-inflamatory effect and potentially having healthy

influences on our blood pressure and blood clotting [3].

 

The rate of cancer among Mediterranean populations is also

significantly

lower than the rest of the world. There is some preliminary evidence

to suggest that these lower rates of cancer, particularly breast

cancer, may also be at least in part due to olive oil consumption, as a

component of olive oil called 'oleic acid' has shown the potential to prevent

breast cancer in laboratory studies.

For these reasons, extra-virgin olive oil intake, especially when

used to replace fat intake from saturated fat sources, should be an

important part of a nutra-smart diet.

 

Olive Oil and Coronary Heart Disease (CHD)

 

Epidemiology

 

Several epidemiological (population-based) studies have found

significantly lower rates of death from all causes, particularly

heart disease, among those whose dietary habits are closets to traditional

Mediterranean diets (rich in plant foods, olive oil and low in saturated animal

fats). [4,5]

Recently, researchers from the University Of Athens School Of

Medicine reviewed all of the epidemiological studies which evaluated the

association between adherence to a Mediterranean diet and the

occurrence of coronary heart disease outcomes. These studies showed that

Mediterranean diet adherence resulted in a reduction in the risk of CHD varying

from 8% to 45%. [6]

 

The seven countries study followed approximately 13,000 healthy

middle aged men from Europe, Japan and the U.S. for 15 years. [7]

Throughout this time, a total of 2,288 of the men had died. Analyses of the

participant's dietary habits revealed that although total fat intake

and polyunsaturated fat intake were not significantly correlated with the risk

of death, the greatest dietary correlation was the intake of monounsaturated

fats. Those who consumed a greater ratio of mono-unsaturated fats to saturated

fats had the most protection

against all causes of death, especially CHD. The greatest source of

monounsaturated fats among most of these countries was of course

olive

oil. Additionally, the populations with the highest monounsaturated

fat

intakes had the lowest rates of heart disease throughout this study.

 

A recent case-control study in Spain compared the diets of 171

patients

who had recently suffered a non-fatal heart attack, with 171 non-

heart

attack patients of the same age (age-matched controls). [8] The

results

of this study found that those who consumed the most olive oil had

an

82% reduced risk of heart attack compared with those who rarely

consumed

olive oil.

 

These studies provide at least some good evidence that adherence to

a

Mediterranean-like diet low in saturated fats and high in

monounsaturated fats, specifically rich in olive oil, may

significantly

decrease the risk of heart disease. Discussed below are some of the

mechanisms by which Olive oil may exert its cardio-protective

effect,

such as it's ability to lower total and LDL " bad " cholesterol

levels,

reduce LDL cholesterol oxidation, increase HDL " good " cholesterol

levels, inhibit unnecessary blood clotting, exert an anti-

inflammatory

action and lower blood pressure in hypertensive patients, as well as

the

potent anti-oxidant properties of olive oils non-fat components such

as

its phenolic content; particularly higher in the lesser-processed

" extra-virgin " olive oil.

 

Effect of Olive Oil on Total and LDL " bad " Cholesterol

 

Many human clinical trials have shown that replacement of high

saturated

fat diets for diets high in monounsaturated fats, mostly from olive

oil,

have resulted in a significant decrease in both total cholesterol

(TC)

and particularly LDL " bad " cholesterol; the type of cholesterol

known to

build up in the arteries and cause atherosclerosis; the hardening

and

narrowing of the arteries that may lead to blockages and coronary

heart

disease (CHD) or stroke. These results have been confirmed in

studies

involving both men and women of varying ages. [9-16]

 

Whilst higher levels of LDL cholesterol (also known as " bad "

cholesterol) are associated with the development of atherosclerosis

and

thus increase the risk of cardiovascular disease, [17-20] higher

levels

of high density lipoprotein (HDL) cholesterol, also referred to as

" good " cholesterol, is associated with a reduced risk of developing

cardiovascular disease. [21] This is because the HDL particles carry

cholesterol away from the arteries and back to the liver, whereas

LDL

particles carry it from the liver and deposit it in the arteries

where

it causes atherosclerosis and plaque build- up. Some studies have

also

shown an increase in HDL " good " cholesterol after olive oil

consumption

[22] as well as other beneficial effects on blood lipid (fat) levels

such as reduction in the levels of apolipoprotein B and beneficial

changes in platelet function. [23] This is important because higher

levels of apolipoprotein B are also associated with an increased

risk of

cardiovascular disease, and blood platelets are also involved in the

development of atherosclerosis by stimulating arterial plaque growth

when they come in contact with the inner wall of blood vessels.

 

LDL particles themselves only become a problem when they are taken

up by

a type of white blood cell found in arterial plaques called

macrophages,

and become oxidized, forming " foam cells " . When these LDL particles

become oxidized and form foam cells, this further stimulates the

progression of plaque build up in arterial walls, hardening and

narrowing the arteries. Therefore, decreasing the amount of LDL

particles in the blood is an important means of preventing

atherosclerosis development, but trying to limit the amount of

oxidization of those LDL particles that are present, is also

important.

This leads to the next important point.

 

LDL Oxidation

 

Diets high in saturated fatty acids (SUFA's) are known to raise LDL

levels whilst diets high in polyunsaturated fatty acids (PUFA's) and

monounsaturated fatty acids (MUFA's) tend to decrease LDL levels. In

fact, a meta-analysis of 27 human trials designed to examine the

effect

of polyunsaturated and monounsaturated fatty acid rich diets on

blood

lipid levels found that both types of dietary fats may potentially

lower

total and LDL cholesterol levels. [24]

 

The problem with diets high in PUFA's however, is that although they

may

decrease the total levels of LDL particles in the blood, they tend

to

create a higher concentration of polyunsaturated fats within the LDL

particles, which in turn increases the amount of LDL oxidation.

[25,26]

This is because PUFA's are more readily oxidized than MUFA's due to

the

higher number of double bonds in their hydrocarbon chains.

 

Human trials have found that subjects given a diet high in Olive Oil

and

other oils rich in monounsaturated fats such as Oleic acid, have not

only been able to lower LDL levels but significantly decreased LDL

oxidation, particularly compared to those given a high PUFA diet.

[27-33]

 

Anti-hypertensive action

 

Epidemiological studies have not always found a correlation between

fat

intake and high-blood pressure (hypertension). [34-36] In regards to

Olive oil however, a cross-sectional study which compared the fatty

acid

levels of middle aged men throughout Europe, found that Italian men

had

significantly higher tissue levels of Oleic acid ( a type of MFA

found

in Olive oil), and also had lower blood pressures.[37]

 

Most clinical trials have found no difference in blood pressure

among

normotensive subjects (people with normal blood pressure) when given

Mediterranean-type diets. [38,39] One trial however found that

healthy

patients given a diet high in Olive oil (40% fat, 22% MUFA) had

reductions in blood pressure when compared to those given the

National

Cholesterol Education Program (NCEP) Step 1 diet (30% fat, 12% MUFA)

[40]

 

Another trial found that giving a diet high in saturated fats to

people

who were used to consuming a Mediterranean style diet (low in SFA,

high

in MUFA) significantly increased their blood pressure. When they

resumed

their normal Mediterranean style diet however, their blood pressure

went

back to normal. [41]

 

These studies however examined the effect of Olive oil containing

diets

in normotensive people (people with normal blood pressure). The

results

of a randomized, crossover trial involving 23 hypertensive patients

(people with high-blood pressure) who were given different diets

over a

year, found that extra virgin olive oil significantly decreased the

need

for anti-hypertensive medications. It was suggested that this occurs

due

to the ability of phenolic compounds found in un-processed

(extra-virgin) olive oils to enhance nitric oxide (NO) levels. [42]

This

study provides preliminary evidence that whilst Olive oil may not

significantly affect blood pressure in normotensive individuals, it

may

have at least some beneficial effects in patients with high blood

pressure.

 

Non-fatty acid components

 

Although it has been speculated that the beneficial effects of a

Mediterranean-like diet are due to certain MUFA's such as Oleic acid

in

Olive oil, recent investigations have found that the non-fatty acid

component of olive oil such as certain phenols, possess beneficial

biologic activities that may contribute to the lower incidence of

coronary heart disease (CHD) in the Mediterranean area. [43] This is

why

Olive oil, particularly " extra virgin olive oil " , may be healthier

than

other foods and oils high in MUFA's. In fact, the main peculiarity

of

extra-virgin olive oil is the presence of remarkable quantities of

phenolic compounds which not only provide high stability and strong

taste but may be at least in part responsible for extra-virgin olive

oils anti-atherogenic potential (the ability to inhibit the

development

of atherosclerotic plaques). [44,45]

 

Many of these beneficial phenolic compounds are not present in other

oils, and are lost in the processing that occurs in olive oils other

than those classed as " extra virgin " . " Extra-virgin " olive oil is

considered the best, is the least processed and is made from the

first

pressing of the olives. " Virgin " olive oil comes from the second

pressing and has lost much of the beneficial phenolic

compounds. " Pure "

olive oil is actually even less pure than " virgin " and " extra-

virgin "

because it undergoes more processing such as filtering and refining.

" Extra light " olive oil undergoes even more processing. Because

further

processing results in further losses of these antioxidant phenols,

" extra-virgin " olive oil is the most pure form and contains the

highest

concentration of phenolic compounds.

 

Among the protective phenolic compounds found in extra-virgin olive

oil

are the antioxidants Hydroxytyrosol [46] and oleuropein, both of

which

are readily absorbed by the body [47] and have shown to possess

potent

free-radical scavenging properties. [48] Studies have shown that

administration of even relatively low doses of olive oil phenols can

significantly increase antioxidant levels in the body and decrease

oxidative stress in both humans [49] and animals. [50]

 

Anti-inflammatory effect

 

Laboratory studies have also shown anti-inflammatory effects of

olive

oil. Rats fed virgin olive oil had less inflammation when injected

with

carrageenan (a substance used to induce arthritis) than what rats

fed

other oils did. Moreover, the rats fed virgin olive oil with an

added

phenolic component (similar to that found in extra virgin olive oil)

had

even less inflammation. [51]

 

A similar study found that both the " un-saponifiable fraction " (non-

fat

portion) of virgin olive oil including beta-sitosterol and

erythrodiol,

as well as its phenolic compounds oleuropein, tyrosol,

hydroxytyrosol

and caffeic acid, all exerted a significant anti-inflammatory effect

almost as effective as the anti-inflammatory drug indomethacin (an

NSAID) did. [52]

 

The anti-inflammatory properties of olive oil's non-fat components

may

also contribute towards its cardio-protective effects, as

inflammation

and inflammatory responses of the vascular endothelium are known to

play

an important role in the development of atherosclerosis. [53,54]

 

Anti-platelet activity

 

Laboratory studies have also found that 2-(3,4-di-hydroxyphenyl)-

ethanol

(DHPE), a phenol component of extra-virgin olive oil with potent

antioxidant properties, is able to inhibit platelet aggregation

(blood

clotting) more effectively that other flavonoids (a class of

antioxidant

polyphenols found in plant foods known to have potentially healthful

effects on a multitude of common chronic health problems). The

phenol

enriched portion of olive oil also demonstrated similar activity.

[55]

 

This is important because heart attacks and strokes are caused by

blood

clots which build up in the arteries of the heart or brain which

have

been narrowed due to atherosclerotic plaque formation. The ability

to

form normal blood clots to physical trauma is of course necessary to

prevent haemorrhage (uncontrolled bleeding), however the degree of

blood

clot inhibition which would occur due to olive oil consumption would

not

be so severe that it would be dangerous at all.

 

Anti-Oxidant Components

 

Olive oil is very high in vitamin E, but other than that, most of

its

antioxidant properties come from its phenolic components. Phenolic

compounds such as flavonoids are widespread in many plant foods and

influence the quality, palatability, and stability of foods by

acting as

flavourants, colourants, and antioxidants. When consumed, certain

phenolic compounds are known to exhibit pharmacological effects on

the

body, such as anti-carcinogenic (anti-cancer), anti-inflammatory,

anti-oxidant, anti-atherogenic effects etc. [56]

 

Laboratory investigations have found that the phenolic constituents

of

olive oil can significantly inhibit the oxidation of LDL " bad "

cholesterol. [57,58] Animal experiments have revealed that greater

reductions in LDL oxidation occurred in rats, rabbits and hamsters

when

fed olive oil than when fed oils similar to olive oil other than its

phenolic components. [59-61] Human investigations have revealed

greater

reductions in LDL oxidation when given extra-virgin olive oil or

virgin

olive oil with a higher phenolic content than when given other olive

oils. [62,63]

 

These studies suggest that the reduction in LDL oxidation that

occurs

after consumption of extra-virgin olive oil may be due to its

phenolic

constituents rather than just its monounsaturated Oleic acid and

vitamin

E content.

 

 

Animal studies have shown that rats fed olive oil enriched with the

non-fatty acid components had greater beneficial effects on

HLD " good "

cholesterol than did those fed ordinary virgin olive oil, or oil

enriched with Oleic acid. [64] This study suggests that substances

other

than the fatty acid in olive oil may exert beneficial effects on the

cardiovascular system.

 

The Bottom Line

 

This evidence strongly suggests not only that Olive oil has superior

protective effects than other foods high in monounsaturated fatty

acids

(MUFA's) due to its non-fat components, but extra-virgin olive oil

may

be the most beneficial type of olive oil due to its higher

concentration

of these protective non-fat components, including a variety of

phenolic

compounds and other antioxidants.

 

Olive Oil and Breast Cancer

 

Epidemiology

 

It has been found that the rates of cancer among the Mediterranean

populations are significantly lower than the rest of Europe and the

United States. This has been attributed to the high dietary intake

of

plant foods and olive oil. [65] Although it has been observed that

per

capita fat consumption around the world is highly correlated with

breast

cancer incidence and mortality, [66,67] the incidence rates of

breast

cancer in Mediterranean countries are relatively low compared with

those

in most other Western countries [68] despite Mediterranean diets

being

relatively high in fat. In fact, the incidence of breast cancer in

Spain

is about 40% lower than that in the U.S, Canada or northern Europe.

[69]

Studies have shown that Greek women derive approximately 42% of

their

energy intake from fat, (mostly from olive oil), [70] however they

have

a substantially lower rate of death from breast cancer than women in

the

U.S, despite American women deriving only 35% of their average

energy

intake from fat. [71]

 

Several case-control studies throughout Mediterranean populations

have

found that women who consume olive oil frequently have a reduced

risk of

breast cancer. Among these was a study in Spain which compared the

diets

of 100 breast cancer patients with 100 women without breast cancer.

The

results showed 70% less breast cancer among frequent consumers of

olive

oil. [72]

 

Another study in Greece compared the diets of 820 women diagnosed

with

breast cancer and 1,548 women without breast cancer. This study

found a

25% reduction in breast cancer risk among the more frequent

consumers of

olive oil. [73] The other case-control studies conducted in Spain

[74]

and Italy [75,76] also found a modest protective association between

olive oil consumption and breast cancer.

 

Oleic Acid

 

Although it is not clear precisely what component of olive oil its

protective effect on breast cancer can be attributed to, it has been

suggested that a type of fatty acid called Oleic acid may be at

least in

part responsible. Animal studies have found that olive oils higher

in

Oleic acid have prevented carcinogen-induced breast cancer better

than

olive oils with lower concentrations of Oleic acid. [77]

 

Recent Laboratory studies have found that Oleic acid can induce

apoptosis (normal cell death which fails to occur in cancer cells)

in

breast cancer cells. It was found that Oleic acid can significantly

reduced the levels of a gene called Her-2/neu - which is thought to

trigger breast cancer. [78] This gene is found in high levels in

around

one in five breast cancer patients and is associated with a poor

prognosis.

 

Further research is needed to better understand what kind of anti-

cancer

activity olive oil may possess.

 

REFERENCES

 

[1] Ferro-Luzzi A, Branca F: Mediterranean diet, Italian type:

prototype

of a healthy diet. Am J Clin Nutr 61: 1338S-1345S (1995).

 

[2] Keys A, Menotti A, Karvonen MJ, et al.: The diet and 15-year

death

rate in the Seven Countries Study. Am J Epidemiol 124: 903-915

(1986).

 

[3] Visioli F, Galli C. Biological properties of olive oil

phytochemicals. Crit Rev Food Sci Nutr. 2002;42(3):209-21.

 

[4] Martinez-Gonzalez MA, Fernandez-Jarne E, Serrano-Martinez M,

Marti

A, Martinez JA, Martin-Moreno JM. Mediterranean diet and reduction

in

the risk of a first acute myocardial infarction: an operational

healthy

dietary score. Eur J Nutr. 2002 Aug;41(4):153-60.]

 

[5] Panagiotakos DB, Pitsavos Ch, Chrysohoou Ch, Stefanadis Ch,

Toutouzas P. The role of traditional mediterranean type of diet and

lifestyle, in the development of acute coronary syndromes:

preliminary

results from CARDIO 2000 study. Cent Eur J Public Health. 2002

Jun;10(1-2):11-5.

 

[6] Panagiotakos DB, Pitsavos C, Polychronopoulos E, Chrysohoou C,

Zampelas A, Trichopoulou A. Can a Mediterranean diet moderate the

development and clinical progression of coronary heart disease? A

systematic review Med Sci Monit. 2004 Aug;10(8):RA193-8. Epub 2004

Jul

23.

 

[7] Keys A, Menotti A, Karvonen MJ, et al.: The diet and 15-year

death

rate in the Seven Countries Study. Am J Epidemiol 124: 903-915

(1986).

 

[8] Fernandez-Jarne E, Martinez-Losa E, Prado-Santamaria M,

Brugarolas-Brufau C, Serrano-Martinez M, Martinez-Gonzalez MA. Risk

of

first non-fatal myocardial infarction negatively associated with

olive

oil consumption: a case-control study in Spain. Int J Epidemiol.

2002

Apr;31(2):474-80.

 

[9] Berry EM, Eisenberg S, Haratz D, Frielander Y, Norman Y,

Kaufmann

NA, Stein Y. Effects of diets rich in monounsaturated fatty acids on

plasma lipoproteins - The Jerusalem Nutrition Study: high MUFAs vs

high

PUFAs. Am J Clin Nutr 53: 899-907 (1991)

 

[10] Berry EM, Eisenberg S, Frielander Y, et al. Effects of diets

rich

in monounsaturated fatty acids on plasma lipoproteins - The

Jerusalem

Nutrition Study II: monounsaturated fatty acids vs carbohydrates. Am

J

Clin Nutr 56: 394-403 (1992)

 

[11] Berry EM, Eisenberg S, Friedlander Y, Harats D, Kaufmann NA,

Norman

Y, Stein Y. Effects of diets rich in monounsaturated fatty acids on

plasma lipoproteins. The Jerusalem Nutrition Study: monounsaturated

vs

saturated fatty acids. Nutr Metab Cardiovasc Dis 5: 55-62 (1995)

 

[12] Gustafsson IB, Vessby B, Nydahl M. Effects of lipid-lowering

diets

enriched with monounsatured and polyunsaturated fatty acids on serum

lipoprotein composition in patients with hyperlipoproteinaemia.

Atherosclerosis 96: 109-118 (1992)

 

[13] Gustafsson IB, Vessby B, Öhrvall M, Nydahl M. A diet rich in

monounsaturated rapeseed oil reduces the lipoprotein cholesterol

concentration and increases the relative content of n-3 fatty acids

in

serum in hyperlipidemic subjects. Am J Clin Nutr 59: 667-674 (1994)

 

[4] Mata P, Garrido JA, Ordovas JM, et al. Effect of dietary

monounsaturated fatty acids on plasma lipoproteins and

apolipoproteins

in women. Am J Clin Nutr 56: 77-83 (1992)

 

[15] Mensink RP, Katan MB. Effect of a diet enriched with

monounsaturated or polyunsaturated fatty acids on levels of low-

density

and high-density lipoprotein cholesterol in healthy women and men. N

Engl J Med 321: 436-441 (1989)

 

[16] Wahrburg U, Martin H, Sandkamp M, Schulte H, Assmann G.

Comparative

effects of a recommended lipid-lowering diet vs a diet rich in

monounsaturated fatty acids on serum lipid profiles in healthy young

adults. Am J Clin Nutr 56: 678-683 (1992)

 

[17] European Atherosclerosis Society (EAS). Prevention of coronary

heart disease: scientific background and new clinical guidelines.

Recommendations of the European Atherosclerosis Society prepared by

the

International Task Force for Prevention of Coronary Heart Disease.

Nutr

Metab Cardiovasc Dis 2: 113-156 (1992)

 

[18] Frick MH, Elo O, Haapa K, et al. Helsinki Heart Study:

Primary-prevention trial with gemfibrozil in middle-aged men with

dyslipidemia: Safety of treatment, changes in risk factors, and

incidence of coronary heart disease. N Engl J Med 317: 1237-1245

(1987)

 

[19] Internation Lipid Information Bureau. The ILIP Lipid Handbook

for

Clinical Practice. Blood Lipids and Coronary Heart Disease. 1995

 

[20] Lipid Research Clinics Program. The Lipid Research Clinics

Coronary

Primary Prevention Trial results. II. The relationship of reduction

in

incidence of coronary heart disease to cholesterol lowering. JAMA

251:

365-374 (1984)

 

[21] National Institutes of Health. National Cholesterol Education

Programm. Second Report of the Expert Panel on Detection,

Evaluation,

and Treatment of High Blood Cholesterol in Adults (Adult Treatment

Panel

II). NIH Publication No. 93-3095, September 1993

 

[22] Mata P, Alvarezsala LA, Rubio MJ, Nuno J, De Oya M. Effects of

long-term monounsaturated-enriched vs polyunsaturated-enriched diets

on

lipoproteins in healthy men and women. Am J Clin Nutr 55: 846-850

(1992)

 

[23] Sirtori CR, Tremoli E, Gatti E, et al. Controlled evaluation of

fat

intake in the Mediterranean diet: comparative activities of olive

oil

and corn oil on plasma lipids and platelets in high-risk patients.

Am J

Clin Nutr 44: 635-642 (1986)

 

[24] Mensink RP, Katan MB. Effect of a dietary fatty acids on serum

lipids and lipoproteins - A meta-analysis of 27 trials.

Arteriosclerosis

Thromb 12: 911-919 (1992)

 

[25] Reaven P, Parthasarathy S, Grasse BJ, et al.: Feasibility of

using

an oleate-rich diet to reduce the susceptibility of low-density

lipoprotein to oxidative modification in humans. Am J Clin Nutr 54:

701-706 (1991).

 

[26] Bonanome A, Pagnan A, Biffanti S, et al.: Effect of dietary

monounsaturated fatty acids on the susceptibility of plasma low

density

lipoproteins to oxidative modification. Arterioscler Thromb 12: 529-

533

(1992).

 

[27] Reaven P, Parthasarathy S, Grasse BJ, et al.: Feasibility of

using

an oleate-rich diet to reduce the susceptibility of low-density

lipoprotein to oxidative modification in humans. Am J Clin Nutr 54:

701-706 (1991).

 

[28] Bonanome A, Pagnan A, Biffanti S, et al.: Effect of dietary

monounsaturated fatty acids on the susceptibility of plasma low

density

lipoproteins to oxidative modification. Arterioscler Thromb 12: 529-

533

(1992).

 

[29] Reaven P, Parthasarathy S, Grasse BJ, et al.: Effects of

oleate-rich and linoleate-rich diets on the susceptibility of low

density lipoprotein to oxidative modification in mildly

hypercholesterolemic subjects. J Clin Invest 91: 668-676 (1993)

 

[30] Abbey M, Belling GB, Noakes M, et al.: Oxidation of low-density

lipoproteins: intraindividual variability and the effect of dietary

linoleate supplementation. Am J Clin Nutr 57: 391-398 (1993).

 

[31] Mata P, Alonso R, Lopez-Farre A, et al.: Effect of dietary fat

saturation on LDL oxidation and monoycte adhesion to human

endothelial

cells in vitro. Arterioscler Throm Vasc Biol 16: 1347-1355 (1996).

 

[32] Berry EM, Eisenberg S, Friedlander Y, et al.: Effects of diets

rich

in monounsaturated fatty acids on plasma lipoproteins-the Jerusalem

Nutrition study. II Monounsaturated fatty acids vs carbohydrates. Am

J

Clin Nutr 56: 394-403 (1992).

 

[33] Aviram M, Eias K: Dietary olive oil reduces low-density

lipoprotein

uptake by macrophages and decreases the susceptibility of the

lipoprotein to undergo lipid peroxidation. Ann Nutr Metab 37: 75-84

(1993).

 

[34] Stamler J, Caggiula A, Grandits A: Relationships of dietary

variables to blood pressure (BP): findings of the Multiple Risk

Factor

Intervention Trial (MRFIT). Circulation 85: 867 ( 1992).

 

[35] Witteman J, Willett W, Stampfer M, et al.: A prospective study

of

nutritional factors and hypertension among US women. Circulation 80:

1320-1327 (1989).

 

[36] Ascherio A, Rimm E, Giovannucci E, et al.: A prospective study

of

nutritional factors and hypertension among US men. Circulation 86:

1475-1484 (1992).

 

[37] Riemersma RA, Wood DA, Butler RA, et al.: Linoleic acid content

in

adipose tissue and coronary heart disease. BMJ 292: 1423-1427 (1986).

 

[38] Mensink R, Janssen M, Katan M: Effect on blood pressure of two

diets differing in total fat but not in saturated and

polyunsaturated

fatty acids in healthy volunteers. Am J Clin Nutr 47: 976-980 (1988).

 

[39] Mensink R, Stowijk A, Katan M: Effect of monounsaturated diet

versus polyunsaturated fatty acid enriched diet on blood pressure in

normotensive women and men. Eur J Clin Invest 20: 463-469 (1990).

 

[40] Espino-Montoro A, Lopez-Miranda J, Castro P, et al.:

Monounsaturated fatty acid enriched diets lower plasma insulin

levels

and blood pressure in healthy young men. Nutr Metab Cardiovasc Dis

6:

147-154 (1996).

 

[41] Strazullo P, Ferro-Luzzi A, Saini, A, et al.: Changing the

Mediterranean diet: effects on blood pressure. J Hypertension 4: 407-

412

(1986).

 

[42] Ferrara, L. A.; Raimondi, A. S.; d'Episcopo, L.; Guida, L.;

Dello,

R. A.; Marotta, T. Olive Oil and Reduced Need for Antihypertensive

Medications. Arch. Intern. Med.2000,160, 837-842.

 

[43] Visioli, F.; Galli, C. The Effect of Minor Constituents of

Olive

Oil on Cardiovascular Disease: New Findings. Nutr. Rev. 1998,56,

142-147.

 

[44] Visioli, F.; Galli, C. Antiatherogenic Components of Olive Oil.

Curr. Atheroscler. Rep.2001,3, 64-67.

 

[45] Visioli, F.; Poli, A.; Gall, C. Antioxidant and Other

Biological

Activities of Phenols From Olives and Olive Oil. Med Res Rev

2002,22,

65-75.

 

[46] Deiana, M.; Aruoma, O. I.; Bianchi, M. L.; Spencer, J. P.;

Kaur,

H.; Halliwell, B.; Aeschbach, R.; Banni, S.; Dessi, M. A.; Corongiu,

F.

P. Inhibition of Peroxynitrite Dependent DNA Base Modification and

Tyrosine Nitration by the Extra Virgin Olive Oil-Derived Antioxidant

Hydroxytyrosol. Free Radic. Biol. Med.1999,26, 762-769.

 

[47] Vissers, M. N.; Zock, P. L.; Roodenburg, A. J.; Leenen, R.;

Katan,

M. B. Olive Oil Phenols Are Absorbed in Humans. J Nutr 2002,132,

409-417.

 

[48] Visioli, F.; Bellomo, G.; Galli, C. Free Radical-Scavenging

Properties of Olive Oil Polyphenols. Biochem. Biophys. Res.

Commun.1998,247, 60-64.

 

[49] Visioli, F.; Caruso, D.; Galli, C.; Viappiani, S.; Galli, G.;

Sala,

A. Olive Oils Rich in Natural Catecholic Phenols Decrease

Isoprostane

Excretion in Humans. Biochem Biophys Res Commun 2000, 278, 797-799.

 

[50] Visioli, F.; Galli, C.; Plasmati, E.; Viappiani, S.; Hernandez,

A.;

Colombo, C.; Sala, A. Olive Phenol Hydroxytyrosol Prevents Passive

Smoking-Induced Oxidative Stress. Circulation 2000,102, 2169-2171.

 

[51] Martinez-Dominguez, E.; de la, P. R.; Ruiz-Gutierrez, V.

Protective

Effects Upon Experimental Inflammation Models of a

Polyphenol-Supplemented Virgin Olive Oil Diet. Inflamm. Res 2001,50,

102-106.

 

[52] de la, P. R.; Martinez-Dominguez, E.; Ruiz-Gutierrez, V. Effect

of

Minor Components of Virgin Olive Oil on Topical Antiinflammatory

Assays.

Z Naturforsch. [C. ]2000,55, 814-819.

 

[53] Zebrack JS, Anderson JL. Role of inflammation in

cardiovascular

disease: how to use C-reactive protein in clinical practice Prog

Cardiovasc Nurs. 2002 Fall;17(4):174-85.

 

[54] Shen CX, Chen HZ, Ge JB. The role of inflammatory stress in

acute

coronary syndrome. Chin Med J (Engl). 2004 Jan;117(1):133-9.

 

[55] Petroni, A.; Blasevich, M.; Salami, M.; Papini, N.; Montedoro,

G.

F.; Galli, C. Inhibition of Platelet Aggregation and Eicosanoid

Production by Phenolic Components of Olive Oil. Thromb. Res.1995,

78,

151-160.

 

[56] Decker EA: The role of phenolics, conjugated linoleic acid,

carnosine, and pyrroloquinoline quinone as non essential dietary

antioxidants. Nutr Rev 53: 49-58 (1995).

 

[57] Visioli, F.; Bellomo, G.; Montedoro, G.; Galli, C. Low Density

Lipoprotein Oxidation Is Inhibited in Vitro by Olive Oil

Constituents.

Atherosclerosis 1995, 117, 25-32.

 

[58] Caruso, D.; Berra, B.; Giavarini, F.; Cortesi, N.; Fedeli, E.;

Galli, G. Effect of Virgin Olive Oil Phenolic Compounds on in Vitro

Oxidation of Human Low Density Lipoproteins. Nutr. Metab Cardiovasc.

Dis.1999, 9 , 102-107.

 

[59] Scaccini C, Nardini M, D'Aquino M, et al.: Effect of dietary

oils

on lipid peroxidation and on antioxidant parameters of rat plasma

and

lipoprotein fractions. J Lipid Res 33: 627-633 (1992).

 

[60] Wiseman SA, Mathot JNNJ, de Fouw NJ, Tijburg LBM: Dietary

non-tocopherol antioxidants present in extra virgin olive oil

increase

the resistance of low density lipoproteins to oxidation in rabbits.

Atherosclerosis 120: 15-23 (1996).

 

[61] Wiseman SA, Tijburg LB, van de Put FH. Olive oil phenolics

protect

LDL and spare vitamin E in the hamster. Lipids. 2002 Nov;37(11):1053-

7

 

[62] Ramirez-Tortosa, M. C.; Urbano, G.; Lopez-Jurado, M.; Nestares,

T.;

Gomez, M. C.; Mir, A.; Ros, E.; Mataix, J.; Gil, A. Extra-Virgin

Olive

Oil Increases the Resistance of LDL to Oxidation More Than Refined

Olive

Oil in Free-Living Men With Peripheral Vascular Disease. J Nutr

1999,129, 2177-2183.

 

[63] Marrugat J, Covas MI, Fito M, Schroder H, Miro-Casas E, Gimeno

E,

Lopez-Sabater MC, de la Torre R, Farre M; SOLOS Investigators.

Effects

of differing phenolic content in dietary olive oils on lipids and

LDL

oxidation--a randomized controlled trial. Eur J Nutr. 2004

Jun;43(3):140-7. Epub 2004 Jan 06.

 

[64] Mangas-Cruz, M. A.; Fernandez-Moyano, A.; Albi, T.; Guinda, A.;

Relimpio, F.; Lanzon, A.; Pereira, J. L.; Serrera, J. L.; Montilla,

C.;

Astorga, R.; Garcia-Luna, P. P. Effects of Minor Constituents

(Non-Glyceride Compounds) of Virgin Olive Oil on Plasma Lipid

Concentrations in Male Wistar Rats. Clin Nutr 2001,20, 211-215.

 

[65] Trichopoulou A, Lagiou P, Kuper H, Trichopoulos D. Cancer and

Mediterranean dietary traditions. Cancer Epidemiol Biomarkers Prev.

2000

Sep;9(9):869-73

 

[66] Carroll KK. Experimental evidence of dietary factors and

hormone-

dependent cancers. Cancer Res 1975;35:3374–83.

 

[67] Armstrong B, Doll R. Environmental factors and cancer incidence

and

mortality in different countries, with special reference to dietary

practices. Int J Cancer 1975;15:617–31.

 

[68] Cohen LA, Wynder EI. Do dietary monounsaturated fatty acids

play a

protective role in carcinogenesis and cardiovascular disease? Med

Hypotheses 1990;31:83–9.

 

[69] Esteve J, Kriker A, Ferlay J, Parkin DM. Facts and figures of

cancer in the European Community. Lyon: International Agency for

Research on Cancer, 1993.

 

[70] Trichopoulou A, Toupadaki N, Tzonou A, Katsouyanni K, Manousos

O,

Kada E, et al. The macronutrient composition of the Greek diet:

estimates derived from six case–control studies. Eur J Clin Nutr

1993;47:549–58.

 

[71] Lenfant C, Ernst N. Daily dietary fat and total food-energy

intakes

Third National Health and Nutrition Examination Survey, Phase 1,

1988–91. MMWR 1994;43:116–7, 123–5.

 

[72] Landa M-C, Frago N, Tres A. Diet and the risk of breast cancer

in

Spain. Eur J Cancer Prev 1994;3:313–29.

 

[73] Trichopoulou A, Katsouyanni K, Stuver S, Tzala L, Gnardellis C,

Rimm E, et al. Consumption of olive oil and specific food groups in

relation to breast cancer risk in Greece. J Natl Cancer Inst

1995;87:110–6.

 

[74] Martin-Moreno JM, Willett WC, Gorgojo L, Banegas JR, Rodriguez-

Artalejo F, Fernandez-Rodriguez JC, et al. Dietary fat, olive oil

intake

and breast cancer risk. Int J Cancer 1994;58: 774–80.

 

[75] Toniolo P, Riboli E, Protta F, Charrel M, Cappa APM.

Calorieproviding nutrients and risk of breast cancer. J Natl Cancer

Inst

1989;81:278–86.

 

[76] La Vecchia C, Negri E, Franceschi S, Decarli A, Giacosa A,

Lipworth

L. Olive oil, other dietary fats, and the risk of breast

 

[77] Cohen LA, Epstein M, Pittman B, Rivenson A. The influence of

different varieties of olive oil on N-methylnitrosourea(NMU)-induced

mammary tumorigenesis. Anticancer Res. 2000 Jul-Aug;20(4):2307-12.

 

[78] Menendez JA, Vellon L, Colomer R, Lupu R. Oleic acid, the main

monounsaturated fatty acid of olive oil, suppresses Her-2/neu (erbB-

2)

expression and synergistically enhances the growth inhibitory

effects of

trastuzumab (HerceptinTM) in breast cancer cells with Her-2/neu

oncogene

amplification. Ann Oncol. 2005 Jan 10

 

JoAnn Guest

mrsjo-

www.geocities.com/mrsjoguest/

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...